An epidemic of Type 2 diabetes continues to plague the United States, leading to calls for reassessing how the disease is ...

Marketing and manufacturing practices for compounded GLP-1RA drugs come under FDA scrutiny, prompting policy changes.

In a remarkable rise, Eli Lilly's Mounjaro (tirzepatide) has become India's second-highest selling drug by value within just ...

AstraZeneca has commenced construction of its $4.5bn active pharmaceutical ingredient (API) manufacturing facility in ...

Novo Nordisk is expanding discounted retail options for consumers who want to purchase the weight-loss medications Wegovy and ...

Drugs.com has explained the side effects of popular weight loss drugs as doctors issue a fresh warning over an ‘unusual’ ...

Medications that prevent HIV, shrink tumors and treat seizures were invented with government funding. At research ...

Rhode Island’s Medicaid program is contemplating an end to coverage for GLP-1 drugs prescribed for weight loss. The proposal ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

AstraZeneca’s $4.5 billion investment in Virginia expands its US drug manufacturing footprint, creating 3600 jobs and ...

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug ...

WEIGHT loss drugs such as Ozempic and Wegovy are powerful tools for tackling obesity and lowering the risk of serious disease ...